Table 3.
Adverse pregnancy outcomes screened articles included and deleted
|
|
Included |
|
Deleted |
Reason for deletion
|
|
1. |
Iheozor-Ejiofor et al. 2017 14 (15 RCTs) (Cochrane Review) |
|
Spivakovsky 2018 25 (critical summary of Iheozor-Ejiofor, Cochrane) |
Duplicate (critical summary) |
|
2. |
Polyzos et al. 2010 15 (1 RCT) (Greece) |
|
Baccaglini 2011 26 (critical summary of Polyzos) |
Duplicate (critical summary) |
|
3. |
Kim et al. 2012 16 (12 RCTs...6 post-2008) (US) |
|
Dasanyake 2013 27 (critical summary of Kim) |
Duplicate (critical summary) |
|
4. |
Chambrone et al. 2011 17 (13 RCTs) (Brazil) |
|
Leader 2011 28 (critical summary of Chambrone) |
Duplicate (critical summary) |
|
5. |
Rangel-Rincón et al. 2018 18 2-4 above included in this umbrella review (18 SRs, 19 intervention studies) (Columbia) |
|
Vivares-Builes et al. 2018 29 (Columbia) |
99 SRs but all observational studies. Purpose was to establish association. |
|
6. |
Shah et al. 2013 19 (SR of 13 RCTs) (India) |
|
Corbella et al. 2016 30 (Italy) |
All case-control or cohort studies |
|
7. |
da Silva et al. 2017 20 (4 RCTs) (Brazil)
|
|
Daalderop et al. 2018 31 (The Netherlands) |
23 SRs but all studies were cohort, case-control or CS |
|
8. |
Schwendicke et al. 2015 21 (13 RCTs) (Germany, US, Denmark) |
|
Ide et al. 2013 32 |
No intervention studies |
|
9. |
Lopez et al. 2015 22 (SR of 6 meta-analyses) |
|
|
|
|
10. |
|
|
Abati et al. 2013 33 |
Only case-control studies |
|
11. |
|
|
Teshome et al. 2016 34 |
Only case-control studies |
|
12. |
|
|
Macones et al. 2010 35 |
Editorial of Polyzos |
|
13. |
|
|
Otomo-Corgel et al. 2012 36 |
Literature review |